Company 'knew of drug fears before withdrawal'
Evidence that the painkiller Vioxx might increase the risk of heart attacks and strokes emerged nearly four years before the drug was voluntarily withdrawn from the market, research has shown.
Vioxx, the brand name for rofecoxib, was designed to fight the pain of arthritis. It was launched in May 1999 by Merck & Co Inc. But in September 2004, Merck voluntarily pulled Vioxx following a large trial that was halted early after finding evidence linking Vioxx to a raised risk of cardiovascular events.
In November 2004, Merck's then chief executive Raymond Gilmartin testified before a US Senate finance committee that until the halted trial, there was no suggestion from research data that patients taking Vioxx were at increased risk.
Yesterday, experts from the Mount Sinai School of Medicine in New York writing in the journal Archives of Internal Medicine produced evidence of clear concerns about Vioxx from December 2000 onwards.
Life & Style blogs
Husband creates spreadsheet detailing wife's 'excuses' for turning down sex
UK police to start seizing drivers' mobile phones after all crashes
Want to reduce the risk of disease? Abandon shaking hands, and start bumping fists...
Standing my ground: If sitting is bad for your health, what happens when you stay on your feet for a whole month?
Primark forced to remove skinny-looking mannequin with protruding ribs after customer complaint
- 1 Secret Cinema: Why were Back to the Future screenings cancelled?
- 2 Christians: The world's most persecuted people
- 3 The secret report that helps Israelis to hide facts
- 4 Danish TV reporter is all business up top, all party down below
- 5 Ross Burden dead: MasterChef and Ready Steady Cook star, dies aged 45
£26000 per annum: Ashdown Group: A highly successful international media organ...
£35000 - £41000 per annum + competitive: Progressive Recruitment: QA Manager -...
Very Competitive Salary: Austen Lloyd: LONDON - BANKING / PROPERTY FINANCE - ...
£28000 - £30000 per annum + competitive: Progressive Recruitment: An ambitious...